The British Journal of Pain is a leading publication in the field of Anesthesiology and Pain Medicine, expertly published by SAGE Publications Ltd from the United Kingdom. With an ISSN of 2049-4637 and an E-ISSN of 2049-4645, this journal has established itself as an essential resource for researchers and practitioners alike, achieving an impressive Q2 ranking in its category for 2023, as well as a Scopus rank of #53 out of 136 in Medicine – Anesthesiology and Pain Medicine. The journal spans a broad scope of topics related to pain management, therapeutic practices, and advancements in treatment methodologies, catering to both ongoing research and clinical applications. Researchers and professionals can access a wealth of knowledge that not only supports the academic community but also drives innovative practices in pain management. The British Journal of Pain recognizes the significance of evidence-based research and its application in clinical settings, making it a vital platform for advancing the understanding of pain and improving patient care.

PHYSIOTHERAPY THEORY AND PRACTICE is a leading journal within the realm of physical therapy, sports therapy, and rehabilitation, published by Taylor & Francis Inc. With an ISSN of 0959-3985 and an E-ISSN of 1532-5040, this esteemed journal focuses on the interdisciplinary approaches and clinical practices that advance the science and application of physiotherapy. Ranking in the top 33% of its category as indicated by its Q2 status in the 2023 category quartiles, it serves as an essential conduit for innovative research and evidence-based practices. The journal has been a vital resource since its inception in 1985, continuing to attract contributions that explore the latest developments in rehabilitation and therapy strategies. Although currently not an Open Access journal, PHYSIOTHERAPY THEORY AND PRACTICE remains pivotal in shaping the landscape of health professions, providing insightful articles that empower researchers, practitioners, and students to enhance patient care and treatment strategies in an evolving field.

Pain Physician is a premier journal that plays a critical role in the field of anesthesiology and pain medicine, published by the American Society of Interventional Pain Physicians. With an impressive impact factor and ranked in the Q1 category of Scopus for its significant contributions to the literature, the journal has established itself as a leading source of innovative research and clinical insights since its inception in 1999. Covering a wide array of topics related to pain management, the journal aims to disseminate high-quality studies that inform best practices and enhance patient care. As a well-respected publication, Pain Physician offers essential access to the latest developments and methodologies in pain therapy to researchers, clinicians, and students alike, fostering a deeper understanding of this critical area of medicine. With its commitment to advancing research and practice, Pain Physician is an invaluable resource for those dedicated to improving the quality of life for individuals suffering from chronic pain.

Pain Practice is an esteemed journal published by WILEY, focusing on the vital field of Anesthesiology and Pain Medicine. With an impressive impact factor reflected in its ranking of #30 out of 136 in its category, Pain Practice operates within the Q2 quartile, indicating its significant influence and contribution to research and clinical practices in managing pain. Established in 2004 and set to converge in 2024, this journal is dedicated to publishing high-quality, peer-reviewed articles that cover a wide range of topics related to pain management, therapeutic approaches, and novel interventions. Although it does not currently offer open access, it remains a crucial resource for professionals and researchers in the field, encouraging advancements in treatment methods and enhancing patient care in pain management.

PAIN MEDICINE, published by Oxford University Press, is a leading journal in the disciplines of Anesthesiology and Pain Medicine. With its ISSN 1526-2375 and E-ISSN 1526-4637, this esteemed journal provides a platform for innovative research and clinical advancements in the field of pain management. With an impressive impact factor attributed to its Q1 ranking in both Anesthesiology and Pain Medicine as well as Q2 in Clinical Neurology for 2023, PAIN MEDICINE ensures high visibility and relevance within the scientific community, noted for its diverse contributions from across the globe. The journal's editorial mission focuses on disseminating significant findings that influence contemporary practices and policies in pain management. Scholars and practitioners are encouraged to engage with this vital resource, which shapes the future of pain medicine from its base at Great Clarendon St, Oxford, England, covering a remarkable timeline from 2000 to 2024.

Acta Clinica Croatica is a distinguished open-access journal published by SESTRE MILOSRDNICE UNIVERSITY HOSPITAL in Croatia, dedicated to advancing the field of general medicine. With its publication history extending from 1993 to 2023, the journal serves as a vital platform for researchers and healthcare professionals to disseminate and access the latest findings in clinical practice, public health, and medical education. As of 2023, it holds a Q3 ranking in the miscellaneous medicine category, reflecting its significance within the academic community, ranked at #327 out of 636 in Scopus, placing it within the 48th percentile. This journal not only provides a well-respected avenue for original research but also emphasizes the importance of collaboration in healthcare advancements. Open access since 2001, Acta Clinica Croatica ensures that knowledge is widely available, making it an invaluable resource for students, researchers, and practitioners seeking to stay informed and contribute to the evolving landscape of medicine.

Current Pain and Headache Reports, published by SPRINGER, is a leading journal in the dynamic fields of anesthesiology, pain medicine, and clinical neurology. Since its inception in 2001, this journal has played a pivotal role in disseminating high-quality, peer-reviewed research that addresses the complex challenges associated with pain and headache disorders. With an impressive 2023 impact factor placing it in the Q1 quartile for Anesthesiology and Pain Medicine, and notable rankings in Clinical Neurology, it is a crucial resource for researchers, clinicians, and students seeking to advance their knowledge and practice in these vital areas of medicine. The journal supports a broad spectrum of scholarly activities by publishing original research, reviews, and expert opinion pieces, contributing significantly to the ongoing dialogue in pain management and headache treatment. As a subscription-based journal based in the United States, Current Pain and Headache Reports ensures that all articles meet rigorous scientific standards, fostering innovation and collaboration across multiple disciplines.

JOINT BONE SPINE is a premier peer-reviewed journal dedicated to advancing knowledge in the fields of rheumatology and orthopedics. Published by Elsevier France-Editions Scientifiques Medicales Elsevier, this esteemed journal has established itself as a key resource within the academic community, being categorized in the Q2 quartile of rheumatology journals for 2023. With an impressive impact as denoted by its Scopus rank of #26 out of 73, and a noteworthy 65th percentile, JOINT BONE SPINE serves as a vital platform for innovative research and clinical findings that address bone and joint diseases. The journal promotes open access, which enhances the dissemination of research findings, ensuring that practitioners, researchers, and students alike can easily access the latest developments and methodologies in the field. With a commitment to bridging scientific advances from 2000 to the present and beyond, JOINT BONE SPINE plays a critical role in shaping the future of musculoskeletal medicine and improving patient outcomes worldwide.

The Journal of Neuroimmune Pharmacology, published by Springer, is a premier academic journal dedicated to advancing the field of pharmacology intersecting with neuroscience and immunology. With an outstanding impact factor and proudly positioned in the Q1 quartile across multiple categories, this journal showcases cutting-edge research that enhances our understanding of the neuroimmune system and its pharmacological implications. Established in 2006 and continuing through 2024, it serves as a vital resource for researchers, professionals, and students alike, offering insights into the mechanisms of drug action, disease processes, and therapeutic strategies. As a testament to its excellence, the journal ranks prominently in Scopus metrics within its discipline, making it an essential platform for disseminating high-quality research that drives innovation in immunology, allergy, neuroscience, and pharmacology.

SCHMERZ is a pivotal journal in the fields of anesthesiology, pain medicine, and clinical neurology, published by SPRINGER HEIDELBERG in Germany. With an ISSN of 0932-433X and an E-ISSN of 1432-2129, the journal is celebrated for its rigorous peer-reviewed articles contributing to the understanding and management of pain. Since its inception in 1987, SCHMERZ has developed an impressive readership, ranking in the Q3 category across multiple disciplines, including Anesthesiology and Pain Medicine, and Clinical Neurology. Operating within the 50th percentile for anesthesiology and the 32nd percentile in neurology, the journal stands as a critical resource for practitioners, researchers, and students engaging with current trends and advancements in pain research and treatment. While not currently offering open access options, SCHMERZ continues to strive toward disseminating high-quality research and fostering vital discussions in the management of pain. With a scope that aims to bridge clinical practices with scientific understanding, SCHMERZ invites contributions that will illuminate and advance the multifaceted nature of pain and its treatment.